Skip to content
All research profiles

Healing / recovery

TB-500

Prepared by the ezGLP team. Sources last checked .

Also known as Thymosin Beta-4, TB4

Routes represented in the knowledgebase: Subcutaneous (SubQ).

Educational overview

TB-500 is listed in the ezGLP knowledgebase under Healing / recovery. Evidence and regulatory status can vary by formulation, route, and jurisdiction.

Category
Healing / recovery
Routes represented
Subcutaneous (SubQ)
Approximate library half-life
1.5 hours; formulation-dependent and not dosing guidance
Storage context
Follow the dispensed product or pharmacy label; storage and beyond-use time vary by formulation.

Published literature

Safety evidence

Serious or important: potential immunogenicity, aggregation, impurity, or product-quality risks.

A dependable route-specific human interaction and side-effect profile is not established; this is not evidence of no risk.

Safety evidence source

Interaction evidence

These are general, pairwise evidence notes. Green identifies the potential-synergy category, while Lv3/Lv2/Lv1 communicates evidence strength; it does not guarantee benefit or cancel a safety warning.

Summarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.

For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.